Larson Financial Group’s United Therapeutics UTHR Stock Holding History

Larson Financial Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$99.2K	Buy	183 +2	+1%	+$1.13K	﹤0.01%	1187
2026 Q1	$107K	Sell	181 -4	-2%	-$1.99K	﹤0.01%	960
2025 Q4	$90.1K	Buy	185 +14	+8%	+$6.52K	﹤0.01%	968
2025 Q3	$71.7K	Buy	171 +117	+217%	+$39.3K	﹤0.01%	1028
2025 Q2	$15.5K	Buy	54 +12	+29%	+$3.59K	﹤0.01%	1604
2025 Q1	$12.9K	Buy	42 +17	+68%	+$5.83K	﹤0.01%	1539
2024 Q4	$8.82K	Buy	+25	New	+$9.19K	﹤0.01%	1525

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Norges Bank Oslo, Norway $1T AUM

Larson Financial Group's UTHR Position: Q2 2026 in Review

Larson Financial Group increased its United Therapeutics (UTHR) stake by 1.1% in Q2 2026, buying an estimated $1.13K and bringing the position to 183 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1187.

Larson Financial Group first reported a position in UTHR in Q4 2024 and has held it in 7 quarters since. The position peaked at $107K in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

Larson Financial Group held 183 shares of United Therapeutics worth $99.2K as of Q2 2026.
Larson Financial Group bought 2 United Therapeutics shares in Q2 2026, an estimated $1.13K.
United Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1187 holding.
Larson Financial Group first reported a position in United Therapeutics in Q4 2024 and has held it in 7 quarters since.
Larson Financial Group's United Therapeutics position peaked at $107K in Q1 2026.
878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.